Chemotherapy Overview Lecture
Chemotherapy Overview
- Definition: A type of cancer drug treatment also referred to as “systemic therapy”.
- Types of Systemic Cancer Therapies: Includes endocrine therapy, molecularly targeted therapy, and immunotherapy.
- Common Misconception: Chemotherapy is often viewed as the standard cancer drug treatment, but other forms exist that may not be classified as chemotherapy.
Types of Cancer Therapy
Local Therapies: Treat cancer in a specific area.
- Examples:
- Surgery: Surgical removal of tumors
- External Beam Radiation Therapy: Primarily local targeting.
Systemic Therapies: Address cancer throughout the body.
- Examples:
- Drug therapies
- Cellular therapies
- Radiation administered like drugs (oral or IV).
Chemotherapy Drug Classes
- Mechanisms of Action: Target and damage proliferating cells, impacting DNA or the mitotic apparatus.
- Chemotherapy Categories:
- Alkylating Agents:
- Transfer alkyl groups to DNA and damage it in all cell cycle phases.
- Antimetabolites:
- Interfere with DNA synthesis; can mimic purines/pyrimidines.
- Topoisomerase Inhibitors:
- Prevent DNA unwinding and replication.
- Antimicrotubule Drugs:
- Disrupt microtubule function during cell division.
Detailed Mechanisms of Chemotherapy Drugs
Alkylating Agents
- Mechanism: Alkyl groups react with DNA, causing cross-linking and damage.
- Types: Bifunctional agents have two reactive groups for more effective DNA damage.
Platinum-based Chemotherapy
- Prototype: Cisplatin, discovered through electric current experiments with platinum.
- Mechanism of Action: Similar to alkylating agents; forms DNA cross-links.
Antimetabolites
- RNA/DNA Interaction:
- 5-FU (Fluorouracil):
- Active metabolites inhibit enzymes crucial for nucleotide synthesis (thymidylate synthase).
- 5-FU (Fluorouracil):
- Cytosine Arabinoside (Ara-C):
- Inhibits DNA polymerase leading to halted DNA synthesis.
- Gemcitabine:
- Inhibits ribonucleotide reductase affecting nucleic acid production.
Topoisomerase Inhibitors
- Classes: Camptothecins (Topo I), Epipodophyllotoxins, Anthracyclines (Topo II).
- Stabilizes enzyme-DNA complexes causing double-stranded breaks leading to cell death.
Antimicrotubule Agents
- Mechanism: Bind to tubulin and disrupt microtubule dynamics essential for mitosis.
- Types: Vinca alkaloids (Vincristine, Vinblastine) and taxanes (Paclitaxel).
Resistance Mechanisms
- Cancer Cell Resistance:
- Tumor microenvironment impeding drug efficacy.
- Alterations in drug influx/efflux impacts uptake.
- Enhanced DNA repair mechanisms lead to insensitivity.
Clinical Considerations
- Toxicities:
- Affect rapidly dividing healthy cells: hair loss, gastrointestinal issues, bone marrow suppression.
- Neurological Effects: Nerve damage leading to neurological toxicities and nausea/vomiting due to chemoreceptor activity in the brain.
- Cancer Mitigation: Chemotherapy can lead to secondary cancers and other organ-specific damages over time.
Chemotherapy Efficacy
- Applications:
- Curative in disseminated cancers.
- Adjuvant treatment post-surgery and control of micrometastases.
- Combination with other therapies (e.g. radiation) can enhance efficacy.
- Palliative care for advanced cancers.
Conclusion
- Emphasis: While chemotherapy remains critical in cancer treatment, new paradigms like targeted therapy and immunotherapy are emerging as alternatives that continue to advance cancer care excellence.